FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008903497> ?p ?o ?g. }

• W3008903497 endingPage "1221" @default.
• W3008903497 startingPage "1209" @default.
• W3008903497 abstract "Activating receptor tyrosine kinase RET (rarranged during transfection) gene alterations have been identified as oncogenic in multiple malignancies. RET gene rearrangements retaining the kinase domain are oncogenic drivers in papillary thyroid cancer, non–small-cell lung cancer, and multiple other cancers. Activating RET mutations are associated with different phenotypes of multiple endocrine neoplasia type 2 as well as sporadic medullary thyroid cancer. RET is thus an attractive therapeutic target in patients with oncogenic RET alterations. Multikinase inhibitors with RET inhibitor activity, such as cabozantinib and vandetanib, have been explored in the clinic for tumors with activating RET gene alterations with modest clinical efficacy. As a result of the nonselective nature of these multikinase inhibitors, patients had off-target adverse effects, such as hypertension, rash, and diarrhea. This resulted in a narrow therapeutic index of these drugs, limiting ability to dose for clinically effective RET inhibition. In contrast, the recent discovery and clinical validation of highly potent selective RET inhibitors (pralsetinib, selpercatinib) demonstrating improved efficacy and a more favorable toxicity profile are poised to alter the landscape of RET-dependent cancers. These drugs appear to have broad activity across tumors with activating RET alterations. The mechanisms of resistance to these next-generation highly selective RET inhibitors is an area of active research. This review summarizes the current understanding of RET alterations and the state-of-the-art treatment strategies in RET-dependent cancers." @default.
• W3008903497 created "2020-03-06" @default.
• W3008903497 creator A5043675371 @default.
• W3008903497 creator A5056574871 @default.
• W3008903497 creator A5063199354 @default.
• W3008903497 creator A5066861614 @default.
• W3008903497 creator A5076426660 @default.
• W3008903497 date "2020-04-10" @default.
• W3008903497 modified "2023-10-10" @default.
• W3008903497 title "State-of-the-Art Strategies for Targeting <i>RET</i>-Dependent Cancers" @default.
• W3008903497 cites W1540538142 @default.
• W3008903497 cites W1577002462 @default.
• W3008903497 cites W1594241115 @default.
• W3008903497 cites W1820831656 @default.
• W3008903497 cites W1848939527 @default.
• W3008903497 cites W1854466856 @default.
• W3008903497 cites W1875361486 @default.
• W3008903497 cites W1893424794 @default.
• W3008903497 cites W1905537177 @default.
• W3008903497 cites W1964893667 @default.
• W3008903497 cites W1966702599 @default.
• W3008903497 cites W1966988179 @default.
• W3008903497 cites W1967792499 @default.
• W3008903497 cites W1968517866 @default.
• W3008903497 cites W1969482148 @default.
• W3008903497 cites W1975396905 @default.
• W3008903497 cites W1975782735 @default.
• W3008903497 cites W1976033646 @default.
• W3008903497 cites W1977464433 @default.
• W3008903497 cites W1977933836 @default.
• W3008903497 cites W1979188008 @default.
• W3008903497 cites W1981016629 @default.
• W3008903497 cites W1981083257 @default.
• W3008903497 cites W1982745900 @default.
• W3008903497 cites W1984080345 @default.
• W3008903497 cites W1985539451 @default.
• W3008903497 cites W1985885351 @default.
• W3008903497 cites W1987145801 @default.
• W3008903497 cites W1987566228 @default.
• W3008903497 cites W1990578633 @default.
• W3008903497 cites W1991773026 @default.
• W3008903497 cites W1995082806 @default.
• W3008903497 cites W1996268443 @default.
• W3008903497 cites W1999749908 @default.
• W3008903497 cites W2000347396 @default.
• W3008903497 cites W2007088808 @default.
• W3008903497 cites W2007725161 @default.
• W3008903497 cites W2011509847 @default.
• W3008903497 cites W2012141473 @default.
• W3008903497 cites W2015127215 @default.
• W3008903497 cites W2024570947 @default.
• W3008903497 cites W2025526034 @default.
• W3008903497 cites W2034879994 @default.
• W3008903497 cites W2039233888 @default.
• W3008903497 cites W2052179498 @default.
• W3008903497 cites W2053343049 @default.
• W3008903497 cites W2058185583 @default.
• W3008903497 cites W2058516625 @default.
• W3008903497 cites W2060543813 @default.
• W3008903497 cites W2061612474 @default.
• W3008903497 cites W2065799563 @default.
• W3008903497 cites W2067026376 @default.
• W3008903497 cites W2067487060 @default.
• W3008903497 cites W2071711537 @default.
• W3008903497 cites W2082228129 @default.
• W3008903497 cites W2087614255 @default.
• W3008903497 cites W2089343676 @default.
• W3008903497 cites W2095970362 @default.
• W3008903497 cites W2096393537 @default.
• W3008903497 cites W2100378386 @default.
• W3008903497 cites W2100888136 @default.
• W3008903497 cites W2100945326 @default.
• W3008903497 cites W2107773171 @default.
• W3008903497 cites W2108279506 @default.
• W3008903497 cites W2112256134 @default.
• W3008903497 cites W2119501407 @default.
• W3008903497 cites W2122133689 @default.
• W3008903497 cites W2122956665 @default.
• W3008903497 cites W2127368054 @default.
• W3008903497 cites W2128805986 @default.
• W3008903497 cites W2133271589 @default.
• W3008903497 cites W2134894529 @default.
• W3008903497 cites W2139143694 @default.
• W3008903497 cites W2139680027 @default.
• W3008903497 cites W2146705255 @default.
• W3008903497 cites W2148214379 @default.
• W3008903497 cites W2157170096 @default.
• W3008903497 cites W2158193201 @default.
• W3008903497 cites W2158791155 @default.
• W3008903497 cites W2162711113 @default.
• W3008903497 cites W2165285773 @default.
• W3008903497 cites W2168076926 @default.
• W3008903497 cites W2168404690 @default.
• W3008903497 cites W2170416930 @default.
• W3008903497 cites W2170776898 @default.
• W3008903497 cites W2246525736 @default.
• W3008903497 cites W2260407561 @default.
• W3008903497 cites W2271763089 @default.

• next